**Core Concept:** The NESTROFT (Natriuretic Peptide Test) test is a diagnostic tool used to differentiate between acute heart failure and acute pulmonary embolism (PE). Natriuretic peptides are hormones secreted by the heart in response to increased filling pressure, such as in heart failure or pulmonary embolism.

**Why the Correct Answer is Right:** The correct answer is "C. Acute pulmonary embolism (PE)". The NESTROFT test is a combination of N-terminal pro-B-type natriuretic peptide (NT-proBNP) and D-dimer tests. Since D-dimer is a marker for fibrin degradation, elevated levels indicate recent blood clot formation, such as in PE. NT-proBNP is a cardiac biomarker that increases with augmented filling pressure due to heart failure or PE. A high NT-proBNP level indicates acute heart failure, while a high D-dimer level indicates acute PE.

**Why Each Wrong Option is Incorrect:**

A. "Acute Coronary Syndrome" (ACS) is not the correct answer because ACS primarily involves myocardial ischemia and infarction, while the NESTROFT test is used to differentiate between heart failure and PE.

B. "Acute Heart Failure" is partially correct, as NESTROFT is useful in differentiating acute heart failure from PE. However, NESTROFT is not a diagnostic tool for heart failure itself.

D. "Acute Pulmonary Embolism" is incorrect because the NESTROFT test is used to distinguish between acute heart failure and acute PE, not to diagnose PE directly.

**Clinical Pearl / High-Yield Fact:** The NESTROFT (NT-proBNP and D-dimer) test is a valuable tool in the diagnostic algorithm for acute pulmonary embolism and heart failure. However, it should be used in conjunction with other clinical findings and imaging studies, as a single abnormal test result does not yield a definitive diagnosis. A negative NESTROFT test, however, can help rule out acute pulmonary embolism and heart failure. In cases of indeterminate findings, further evaluation is necessary.